Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
D000818:Animals; D001058:Apomorphine / Q000008:administration & dosage / Q000494:pharmacology*; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects*; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology*; D005071:Evoked Potentials / Q000187:drug effects; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D007478:Iontophoresis; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D011187:Posture / Q000187:drug effects; D013378:Substantia Nigra / Q000166:cytology / Q000187:drug effects*; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced
D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine